Global CBD Nutraceuticals Market Size By Type (CBD Tinctures, Capsules And Softgels), By Application (Retail Stores, Online), By Region, And Segment Forecasts, 2023 to 2032

The Global CBD Nutraceuticals Market was valued at USD 8.1 billion in 2023 and is projected to reach USD 22.5 billion by 2031, expanding at a CAGR of 13.5% during the forecast period from 2023 to 2031. The increasing acceptance of cannabidiol (CBD) in food supplements and wellness products, coupled with growing consumer awareness about the potential health benefits of CBD, is driving market growth. As nutraceuticals become a mainstream component of preventive healthcare, CBD-infused products are gaining significant traction across developed and emerging markets.

Drivers

1. Increasing Awareness of Natural Wellness Products

Consumers are increasingly shifting towards natural and plant-based health solutions. CBD’s anti-inflammatory, anti-anxiety, and pain-relief properties make it a favored ingredient in nutraceutical formulations.

2. Legalization and Regulatory Reforms

Liberalization of cannabis laws across regions, especially in North America and parts of Europe, has paved the way for greater adoption of CBD in the health and wellness industry.

3. Rising Geriatric Population and Chronic Illnesses

The growing aging population and rising incidence of lifestyle-related conditions such as insomnia, arthritis, and anxiety are boosting the demand for non-pharmaceutical and alternative therapies, notably CBD nutraceuticals.

Restraints

1. Regulatory Ambiguities in Several Regions

Despite global progress, several countries still lack clear guidelines for the use of CBD in nutraceuticals, which hampers product launches and market entry strategies.

2. Quality Concerns and Misinformation

The unregulated segment of the market faces challenges related to inconsistent product quality, misleading labeling, and insufficient clinical validation, which can erode consumer trust.

Opportunity

1. Product Innovation in Delivery Formats

Innovative formats like CBD-infused gummies, capsules, tinctures, and beverages are creating new consumer touchpoints. R&D in bioavailability enhancement is another major opportunity for manufacturers.

2. Expansion into Untapped Markets

Emerging markets in Asia-Pacific and Latin America present significant growth opportunities due to evolving wellness trends, urbanization, and increasing disposable incomes.

3. Collaboration with Healthcare Providers

Strategic collaborations with wellness clinics, pharmacies, and healthcare providers can create new distribution channels and enhance credibility.

Market by System Type Insights

By product format, CBD Gummies held the largest market share in 2023, owing to their convenience, taste appeal, and increasing availability. However, CBD Capsules & Softgels are expected to register the fastest growth due to their precise dosing and familiarity among health supplement users.

Market by End-use Insights

The Adults (18-65 years) segment dominated the market in 2023, driven by rising stress levels, sleep disorders, and interest in general wellness. The Geriatric Population segment is expected to grow rapidly due to increasing awareness of CBD's benefits in managing age-related conditions such as arthritis and chronic pain.

Market by Regional Insights

North America led the market in 2023, fueled by high consumer acceptance, favorable regulatory frameworks, and the presence of key players. Meanwhile, Asia-Pacific is anticipated to witness the fastest CAGR due to increasing legalization efforts and growing consumer interest in functional foods and supplements.

Competitive Scenario

Prominent players in the Global CBD Nutraceuticals Market include CV Sciences, Inc., Charlotte’s Web Holdings, Inc., Medterra CBD, Gaia Botanicals LLC, Green Roads, Inc., ENDOCA, Elixinol Global Limited, HempFusion Wellness Inc., and Isodiol International Inc. These companies are leveraging strategic partnerships, product innovations, and geographical expansion to strengthen their market position.

Scope of Work – Global CBD Nutraceuticals Market

Key Market Developments

2023: Charlotte’s Web Holdings launched a new line of CBD gummies with clinically backed formulations targeting stress and sleep.

2024: Medterra CBD entered the Asian market through a joint venture in Japan, aiming to tap into the rising demand for alternative supplements.

2025: Green Roads partnered with a chain of wellness clinics in the U.S. to distribute its line of pharmacist-formulated CBD capsules.

FAQs

1) What is the current market size of the Global CBD Nutraceuticals Market?

The market was valued at USD 8.1 billion in 2023.

2) What is the major growth driver of the Global CBD Nutraceuticals Market?

The primary driver is the increasing consumer demand for natural wellness and functional health supplements.

3) Which is the largest region during the forecast period in the Global CBD Nutraceuticals Market?

North America holds the largest market share due to its regulatory support and advanced consumer base.

4) Which segment accounted for the largest market share in Global CBD Nutraceuticals Market?

CBD Gummies accounted for the largest share owing to their ease of use and consumer appeal.

5) Who are the key market players in the Global CBD Nutraceuticals Market?

Key players include Charlotte’s Web Holdings, CV Sciences, Medterra CBD, Green Roads, and Elixinol Global.